Morgan BP - Search Results

1

Bacterial expression and membrane targeting of the rat complement regulator Crry: a new model anticomplement therapeutic.

Fraser DA, Harris CL, Smith RA, Morgan BP. Fraser DA, et al. Among authors: morgan bp. Protein Sci. 2002 Oct;11(10):2512-21. doi: 10.1110/ps.0212402. Protein Sci. 2002. PMID: 12237472 Free PMC article.

2

Complement therapeutics; history and current progress.

Morgan BP, Harris CL. Morgan BP, et al. Mol Immunol. 2003 Sep;40(2-4):159-70. doi: 10.1016/s0161-5890(03)00111-1. Mol Immunol. 2003. PMID: 12914822 Review.

3

Generation of a recombinant, membrane-targeted form of the complement regulator CD59: activity in vitro and in vivo.

Fraser DA, Harris CL, Williams AS, Mizuno M, Gallagher S, Smith RA, Morgan BP. Fraser DA, et al. Among authors: morgan bp. J Biol Chem. 2003 Dec 5;278(49):48921-7. doi: 10.1074/jbc.M302598200. Epub 2003 Sep 30. J Biol Chem. 2003. PMID: 14519760 Free article.

4

Rat membrane cofactor protein (MCP; CD46) is expressed only in the acrosome of developing and mature spermatozoa and mediates binding to immobilized activated C3.

Mizuno M, Harris CL, Johnson PM, Morgan BP. Mizuno M, et al. Among authors: morgan bp. Biol Reprod. 2004 Oct;71(4):1374-83. doi: 10.1095/biolreprod.104.030114. Epub 2004 Jun 23. Biol Reprod. 2004. PMID: 15215199

5

Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli.

White J, Lukacik P, Esser D, Steward M, Giddings N, Bright JR, Fritchley SJ, Morgan BP, Lea SM, Smith GP, Smith RA. White J, et al. Among authors: morgan bp. Protein Sci. 2004 Sep;13(9):2406-15. doi: 10.1110/ps.03455604. Protein Sci. 2004. PMID: 15322283 Free PMC article.

6

''Homologous restriction'' in complement lysis: roles of membrane complement regulators.

Morgan BP, Berg CW, Harris CL. Morgan BP, et al. Xenotransplantation. 2005 Jul;12(4):258-65. doi: 10.1111/j.1399-3089.2005.00237.x. Xenotransplantation. 2005. PMID: 15943774 Review.

7

Prevention of experimental autoimmune myasthenia gravis by rat Crry-Ig: A model agent for long-term complement inhibition in vivo.

Hepburn NJ, Chamberlain-Banoub JL, Williams AS, Morgan BP, Harris CL. Hepburn NJ, et al. Among authors: morgan bp. Mol Immunol. 2008 Jan;45(2):395-405. doi: 10.1016/j.molimm.2007.06.144. Epub 2007 Jul 24. Mol Immunol. 2008. PMID: 17651804 Free PMC article.

8

Efficient generation of monoclonal antibodies for specific protein domains using recombinant immunoglobulin fusion proteins: pitfalls and solutions.

Harris CL, Lublin DM, Morgan BP. Harris CL, et al. Among authors: morgan bp. J Immunol Methods. 2002 Oct 15;268(2):245-58. doi: 10.1016/s0022-1759(02)00207-7. J Immunol Methods. 2002. PMID: 12215393

9

Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.

Harris CL, Hanna SM, Mizuno M, Holt DS, Marchbank KJ, Morgan BP. Harris CL, et al. Among authors: morgan bp. Immunology. 2003 May;109(1):117-26. doi: 10.1046/j.1365-2567.2003.01628.x. Immunology. 2003. PMID: 12709025 Free PMC article.

10

Generation of anti-complement "prodrugs": cleavable reagents for specific delivery of complement regulators to disease sites.

Harris CL, Hughes CE, Williams AS, Goodfellow I, Evans DJ, Caterson B, Morgan BP. Harris CL, et al. Among authors: morgan bp. J Biol Chem. 2003 Sep 19;278(38):36068-76. doi: 10.1074/jbc.M306351200. Epub 2003 Jul 3. J Biol Chem. 2003. PMID: 12842884 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

537 results

Search Page

Filters